Skip to content

Feasibility of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults

Feasibility of 24-Weeks of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults (ChaREx Study)

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06671847
Acronym
ChaREx
Enrollment
11
Registered
2024-11-04
Start date
2025-03-05
Completion date
2026-01-07
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenic Obesity

Keywords

chair-based resistance band exercise

Brief summary

The purpose of this study is to determine the feasibility of implementing a 24-week at-home chair-based resistance band training intervention, to determine effectiveness of a the a 24-week at-home chair-based resistance band training intervention in improving body composition and to determine the effectiveness of a 24-week at-home chair-based resistance band training intervention in improving physical performance in adults 50 years and older, receiving care at the UT Physicians Center for Healthy Aging.

Interventions

DEVICETHERABand resistance exercise bands

The training will be performed using THERABand resistance exercise bands.Participants will be instructed to perform the exercises twice per week at home, for the 24 weeks duration. Each exercise session will entail 1 set of 15 repetitions of 9 different exercises

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* English-speaking * receive care at the UT Physician Center for Healthy Aging

Exclusion criteria

* inability to provide informed consent on their own * presence of obvious signs of cognitive decline * a diagnosis of dementia and inability to come to the clinic for the scheduled study visits.

Design outcomes

Primary

MeasureTime frame
Feasibility as assessed by the number of people who are able to follow the prescribed exercise regimen at least 50 percent of the timeend of study (24 weeks from baseline)

Secondary

MeasureTime frameDescription
Change in body fatbaseline,6-monthsThis will be assessed using the handheld bioelectrical impedance analysis (BIA) device (Omron HBF-510)
Change in bone mineral density (BMD) of the femoral neck and lumbar spinebaseline, 1 year from baselineThis will be assessed by the Dual energy x-ray absorptiometry (DXA)
Handgrip strengthbaselineThis will be assessed using a validated handgrip dynamometer
60-second balance as assessed by the the Zibrio Stability Pro scaleBaselineThis is determined by the patient standing on the Zibrio Stability Pro Scale unassisted for one minute and will be measured on a scale of 1 to 9 with lower scores indicating higher risk of fall
walking gait speedBaselineGait speed will be assessed over a 6-meter distance measured within a private clinic space. The participant will be instructed to walk at their normal walking pace (as if they were walking throughout the house) and the distance/time will be converted to meters/second.Faster walking speed is related to reduced fall-risk, improved physical function, and greater survival .
Blood level of pro-collagen type 1 N-telopeptide (P1NP)BaselineP1NP is a metabolic marker of bone formation, indicates status of bone loss and a stable or decreased level will be indicating improved metabolism
Frailty as assessed by the Fried criteriaBaselineThis consists of 5 items (unintentional weight loss, weakness \[low grip strength\], slowness low, self-reported exhaustion and low physical activity). Patients who meet 1or 2 of the criteria are described as pre-frail and 3 or more as frail.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORNuzha Amjad, MD

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026